SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-05-23 12:58
Tx date 2023-05-19 		$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights 		$249,994
+29,205 vol
$8.56 each 		150,016
Filed 2023-05-08 10:07
Tx date 2023-05-04 		$BLCO
Bausch + Lomb Corporation 		Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+12,857 vol 		12,857
Filed 2023-04-27 16:52
Tx date 2023-04-24 		$BLCO
Bausch + Lomb Corporation 		Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
57 - Exercise of rights 		$214,000
+12,500 vol
$17.12 each 		12,500
Filed 2023-04-27 16:52
Tx date 2022-05-05 		$BLCO
Bausch + Lomb Corporation 		Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-04-27 16:51
Tx date 2023-04-24 		$BLCO
Bausch + Lomb Corporation 		Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights 		$-214,000
-12,500 vol
$17.12 each 		0
Filed 2022-06-29 13:09
Tx date 2022-06-24 		$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights
+34,387 vol 		120,811
Filed 2022-05-12 09:14
Tx date 2022-05-10 		$BLCO
Bausch + Lomb Corporation 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+12,500 vol 		12,500
Filed 2022-05-12 09:12
Tx date 2022-05-05 		$BLCO
Bausch + Lomb Corporation 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-03 19:55
Tx date 2021-04-30 		$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights 		$249,991
+7,645 vol
$32.70 each 		86,424
Filed 2020-05-04 11:07
Tx date 2020-05-01 		$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights
+11,037 vol 		78,779
Filed 2020-03-16 16:42
Tx date 2020-03-12 		$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$38,837
+2,500 vol
$15.54 each 		11,500
Filed 2019-05-06 11:44
Tx date 2019-05-03 		$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights 		$249,981
+10,633 vol
$23.51 each 		67,742
Filed 2018-05-10
Tx date 2018-05-03 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights
+13,881 vol 		57,109
Filed 2018-05-10
Tx date 2018-05-03 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights
+14,285 vol
Filed 2018-05-04
Tx date 2018-05-03 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights
+14,285 vol 		57,513
Filed 2017-05-08
Tx date 2017-05-05 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights
+25,406 vol 		43,228
Filed 2017-05-08
Tx date 2017-05-05 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights
+25,046 vol
Filed 2016-12-19
Tx date 2016-12-14 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$73,650
+5,000 vol
$14.73 each 		9,000
Filed 2016-07-21
Tx date 2016-06-17 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights 		$374,996
+16,726 vol
$22.42 each 		17,822
Filed 2016-07-21
Tx date 2016-06-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$97,600
+4,000 vol
$24.40 each 		4,000
Filed 2016-07-21
Tx date 2016-03-08 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-15
Tx date 2016-03-11 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
56 - Grant of rights 		$76,226
+1,096 vol
$69.55 each 		1,096
Filed 2016-03-15
Tx date 2016-03-08 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report